CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Open-market buy Chairman and CEO bought 250 shares at $1.59 ($398)
- 4 Open-market buy Chairman and CEO bought 600 shares at an average $1.55 ($931)
- 4 Open-market buy Chairman and CEO bought 1,250 shares at an average $1.61 ($2,013)
- 4 Open-market buy Chairman and CEO bought 1,600 shares at an average $1.50 ($2,401)
- 4 Open-market buy Chairman and CEO bought 1,153 shares at an average $1.62 ($1,867)
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Other events
- 8-K Event Restatement
- 4 Open-market buy Chairman and CEO bought 1,200 shares at $1.74 ($2,088)
- 4 Open-market buy Chairman and CEO bought 1,000 shares at $1.67 ($1,670)
- 4 Open-market buy Chairman and CEO bought 1,500 shares at $1.67 ($2,505)
- 4 Open-market buy Chairman and CEO bought 6,300 shares at an average $1.76 ($11,070)
- 4 Open-market buy Chairman and CEO bought 6,200 shares at an average $1.70 ($10,548)
- 4 Open-market buy Chairman and CEO bought 5,700 shares at an average $1.60 ($9,127)
- 4 Open-market buy Chairman and CEO bought 6,000 shares at an average $1.55 ($9,280)
- 4 Open-market buy Chairman and CEO bought 5,700 shares at an average $1.55 ($8,832)
- 4 Open-market buy Chairman and CEO bought 2,700 shares at an average $1.37 ($3,689)
- 4 Open-market buy Chairman and CEO bought 1,600 shares at an average $1.38 ($2,202)
- 4 Open-market buy Chairman and CEO bought 5,700 shares at an average $1.39 ($7,929)
- 4 Open-market buy Chairman and CEO bought 500 shares at $1.35 ($675)
Page 13 of 63 · 1,250 filings